WT1(235), a ninemer peptide derived from Wilms' tumor gene product, is a candidate peptide for the vaccination of HLA-A*0201-positive patients with hematopoietic malignancies.
Zheyu
Z
Li
Yoshihiro
Y
Oka
Akihiro
A
Tsuboi
Tomoki
T
Masuda
Naoko
N
Tatsumi
Manabu
M
Kawakami
Tatsuya
T
Fujioka
Nao
N
Sakaguchi
Hiroko
H
Nakajima
Fumihiro
F
Fujiki
Keiko
K
Udaka
Yusuke
Y
Oji
Ichiro
I
Kawase
Haruo
H
Sugiyama
D017951:Antigen Presentation / Q000276:immunology*; D019496:Cancer Vaccines / Q000276:immunology; D018984:Epitopes, T-Lymphocyte / Q000276:immunology*; D015234:HLA-A Antigens / Q000276:immunology*; D015789:HLA-A2 Antigen; D019337:Hematologic Neoplasms / Q000276:immunology / Q000628:therapy; D006801:Humans; D020014:K562 Cells; D009842:Oligopeptides / Q000276:immunology*; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology*; D014611:Vaccination / Q000379:methods; D025721:WT1 Proteins / Q000276:immunology*
D019496:Cancer Vaccines; D018984:Epitopes, T-Lymphocyte; D015234:HLA-A Antigens; C435939:HLA-A*02:01 antigen; D015789:HLA-A2 Antigen; D009842:Oligopeptides; D025721:WT1 Proteins